- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe atopic dermatitis
- Meeting Date: November 2024
- Public Summary Document (PSD) November 2024 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) November 2024 PBAC Meeting - (Word 370KB)
Abrocitinib – November 2024
Abrocitinib , Tablet 50 mg, Tablet, 100 mg, Tablet 200 mg; Cibinqo
Last updated
30 May 2025